[Form 4] Astrana Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Astrana Health, Inc. director Thomas S. Lam reported a tax-related share disposition. On March 5, 2026, he surrendered 9,266 shares of common stock at $25.07 per share to cover tax withholding on vested restricted stock, leaving 423,990 shares held directly.

He also reports indirect ownership of 6,132,802 shares of common stock through Allied Physicians of California, a Professional Medical Corporation, and 1,133,706 shares through the Thomas and Jeanette Lam 2002 Family Trust. He disclaims beneficial ownership of the Allied Physicians shares except to the extent of his pecuniary interest.

His direct holdings include restricted stock that may vest later, with 51,667 shares scheduled to vest in two equal annual installments beginning on March 5, 2027, and 26,667 shares vesting upon achievement of pre-established performance goals.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Lam Thomas S.

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	9,266	$25.07	$232K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 423,990 shares (Direct); Common Stock — 6,132,802 shares (Indirect, By Allied Physicians of California, a Professional Medical Corporation)

Footnotes (1)

1. These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lam Thomas S.

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CA 91801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		F		9,266(2)	D	$25.07	423,990(3)	D
Common Stock								6,132,802	I	By Allied Physicians of California, a Professional Medical Corporation(1)
Common Stock								1,133,706	I	By the Thomas and Jeanette Lam 2002 Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

2. Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026.

3. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.

	/s/ Kathy Diep, as Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Astrana Health (ASTH) director Thomas S. Lam report?

Thomas S. Lam reported a tax-withholding disposition of 9,266 shares of Astrana Health common stock. The shares were surrendered on March 5, 2026 to cover tax obligations tied to restricted stock that vested on the same date.

Was the Astrana Health (ASTH) insider transaction an open-market sale?

The reported transaction was a surrender of shares to offset tax withholding obligations, not an open-market sale. It was associated with restricted stock vesting on March 5, 2026, and is classified under transaction code F for tax-related dispositions.

How many Astrana Health (ASTH) shares does Thomas S. Lam hold directly after the transaction?

After the tax-withholding disposition, Thomas S. Lam directly holds 423,990 shares of Astrana Health common stock. This direct position includes restricted stock awards that may vest over time, subject to continued employment and specific performance goals.

What indirect Astrana Health (ASTH) holdings are associated with Thomas S. Lam?

Indirectly, Lam reports 6,132,802 shares held by Allied Physicians of California and 1,133,706 shares held by the Thomas and Jeanette Lam 2002 Family Trust. He disclaims beneficial ownership of the Allied Physicians shares except for his pecuniary interest.

How are future restricted stock awards for Astrana Health (ASTH) director Lam scheduled to vest?

Lam’s reported restricted stock includes 51,667 shares vesting in two equal annual installments starting March 5, 2027, and 26,667 shares that will vest upon achievement of pre-established performance goals, assuming continued employment with Astrana Health.

What does the Form 4 footnote say about Lam’s Allied Physicians of California shares in ASTH?

The filing states Allied Physicians’ shares are beneficially owned by that corporation, where Lam is an executive, director, and stockholder. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, limiting how those shares are attributed to him.